Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302). (Q38854465)
Jump to navigation
Jump to search
scientific article published on 10 July 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302). |
scientific article published on 10 July 2015 |
Statements
1 reference
Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302). (English)
1 reference
Elena Geretti
Shannon Curtis Leonard
Nancy Dumont
Helen Lee
Raquel De Souza
Daniel F Gaddy
Christopher W Espelin
Victor Moyo
Ulrik B Nielsen
Thomas J Wickham
10 July 2015
1 reference